6-Benzylamino-9-(a-D-glucopyranosyl)purine

CAS: 4294-17-1

Ref. 3D-NB04599

Produktinformation

• Name: 6-Benzylamino-9-(a-D-glucopyranosyl)purine
• Synonyme: 6-(Benzylamino)-9-glucosylpurine, 6-(Benzylamino)-9-β-<span class="text-smallcaps">D</span>-glucopyranosylpurine, 6-(Benzylamino)purine 9-β-<span class="text-smallcaps">D</span>-glucopyranoside, 6-Benzylaminopurine 9-(-D-glucoside), 6-Benzylaminopurine-9-glucoside, 9-β-<span class="text-smallcaps">D</span>-Glucopyranosyl-N-(phenylmethyl)-9H-purin-6-amine, 9-β-<span class="text-smallcaps">D</span>-Glucopyranosyl-N-benzyladenine, 9H-Purin-6-amine, 9-β-<span class="text-smallcaps">D</span>-glucopyranosyl-N-(phenylmethyl)-, Adenine, N-benzyl-9-β-<span class="text-smallcaps">D</span>-glucopyranosyl-, Adenine, N⁶-benzyl-9-β-<span class="text-smallcaps">D</span>-glucopyranosyl-, Benzyladenine 9-glucoside, N-Benzyl-9-glucosyladenine, N-Benzyl-9-β-<span class="text-smallcaps">D</span>-glucopyranosyladenine, N⁶-Benzyladenine 9-glucoside

Beschreibung

6-Benzylamino-9-(a-D-glucopyranosyl)purine is a novel nucleoside phosphoramidite that has been synthesized as an intermediate for anticancer therapy. It is a monophosphate, which has antiviral and antifungal activity. 6-Benzylamino-9-(a-D-glucopyranosyl)purine is a synthetic nucleoside with a novel structure, which inhibits the synthesis of DNA and RNA. This drug also has ribonucleotide reductase inhibitory activities.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 387.4 g/mol
• Formel: C₁₈H₂₁N₅O₅
• Reinheit: Min. 95%